First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

October 10, 2018

Study Completion Date

February 26, 2019

Conditions
Multiple Myeloma
Interventions
DRUG

Cyclophosphamide

DRUG

Filgrastim

Trial Locations (12)

33100

Tampere University Hospital, Tampere

70200

Kuopio University Hospital, Kuopio

Unknown

Kanta-Häme Central Hospital, Hämeenlinna

Helsinki University Hospital, Helsinki

Jyväskylä Central Finland Central Hospital, Jyväskylä

Kainuu Kajaani Central Hospital, Kajaani

Länsi-Pohja Central Hospital, Kemi

Kymenlaakso Central Hospital, Kotka

Mikkeli Southern-Savo Central Hospital, Mikkeli

Oulu University Hospital, Oulu

Satakunta Central Hospital, Pori

Turku University Central Hospital, Turku

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Helsinki University Central Hospital

OTHER

collaborator

Tampere University Hospital

OTHER

collaborator

Turku University Hospital

OTHER_GOV

collaborator

Oulu University Hospital

OTHER

collaborator

Mikkeli Central Hospital

OTHER

collaborator

Kymenlaakso Central Hospital Kotka Finland

OTHER

collaborator

Jyväskylä Central Hospital

OTHER

collaborator

Kanta-Häme Central Hospital

OTHER_GOV

collaborator

Satakunta Central Hospital

OTHER

collaborator

Kainuu Central Hospital, Kajaani

OTHER

collaborator

Celgene Corporation

INDUSTRY

lead

Kuopio University Hospital

OTHER

NCT01790737 - First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02 | Biotech Hunter | Biotech Hunter